NorthWest Biotherapeutics Inc (NWBO): I have the facts correct, but you seem t...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	23
Posts	1331
Boards Moderated	1
Alias Born	09/25/2018

JerryCampbell

Re: biosectinvestor post# 247364

Monday, 10/14/2019 12:08:37 AM

Monday, October 14, 2019 12:08:37 AM

I have the facts correct, but you seem to have forgotten. Let's go to the SEC filings.

"As reported in the Company’s quarterly report on form 10-Q, on November 7, 2016 the Company received a letter from Nasdaq indicating that certain of the Company’s financing transactions did not comply with Nasdaq’s Listing Rule 5635(d). The Nasdaq Staff had determined to aggregate a series of transactions that were completed between May 15, 2016 and October 13, 2016 for purposes of assessing whether the 20% threshold for shareholder approval had been triggered for issuances priced below the applicable market price. These transactions included repricing of existing common stock purchase warrants and issuances of new common shares and common stock purchase warrants."

https://www.sec.gov/Archives/edgar/data/1072379/000114420416134282/v453089_8k.htm

DID NOT COMPLY WITH NASDAQ'S LISTING RULE - seems like pretty clear English. And it was nwbo's second violation of the same rule.